Publikation

Phase II study of sunitinib administered in a continuous once-daily dosing regimen in patients with cytokine-refractory metastatic renal cell carcinoma

Wissenschaftlicher Artikel/Review - 01.09.2009

Escudier Bernard, Chen Isan, Maneval Edna Chow, Flodgren Per, Peschel Christian, Fountzilas George, Mulder Sasja F, Srinivas Sandhya, Harmenberg Ulrika, Gillessen Sommer Silke, Roigas Jan, Vogelzang Nicholas J